Expression and inducibility by phenobarbital of CYP2C33, CYP2C42, CYP2C49, CYP2B22, and CYP3As in porcine liver, kidney, small intestine, and nasal tissues

By Puccinelli Emanuela   Gervasi Pier Giovanni   Marca Margherita La   Beffy Pascale   Longo Vincenzo  

Xenobiotica, Vol. 40, Iss. 8, 2010-08 ,pp. : 525-535

Informa Healthcare

Access to resources Recommend Favorite

Characterization of CYP2C19 and CYP2C9 from Human Liver: Respective Roles in Microsomal Tolbutamide, S-Mephenytoin, and Omeprazole Hydroxylations

By Lasker J.M.   Wester M.R.   Aramsombatdee E.   Raucy J.L.  

Archives of Biochemistry and Biophysics, Vol. 353, Iss. 1, 1998-05 ,pp. : 16-28

Elsevier

Access to resources Recommend Favorite

Pituitary component of the aromatic hydrocarbonmediated expression of CYP2B and CYP2C11

By Bergeron R. M.   Serron S. C.   Rinehart J. J.   Cawley G. F.   Backes W. L.  

Xenobiotica, Vol. 28, Iss. 3, 1998-03 ,pp. : 303-312

Informa Healthcare

Access to resources Recommend Favorite

Identification of CYP2C9 as a Human Liver Microsomal Linoleic Acid Epoxygenase

By Draper A.J.   Hammock B.D.  

Archives of Biochemistry and Biophysics, Vol. 376, Iss. 1, 2000-04 ,pp. : 199-205

Elsevier

Access to resources Recommend Favorite

Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development

By Mori K.   Hashimoto H.   Takatsu H.   Tsuda-Tsukimoto M.   Kume T.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 415-422

Informa Healthcare

Access to resources Recommend Favorite